Article
Pharmacogenetics in Cancer Treatment
13 Jan 2003
Abstract excerpt
Interindividual variability in the efficacy and toxicity of drug therapy is associated with polymorphisms in genes encoding drug-metabolizing enzymes, transporters, or drug targets. Pharmacogenetics aims to identify individuals predisposed to high risk of toxicity from conventional doses of cancer chemotherapeutic agents. We review the role of genetic polymorphisms in UGT1A1 and TPMT, as well as mutations in DPD,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
